- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06459856
Combined Effects of Balloon Blowing Therapy With Percussion in Patients With Pneumonia
Combined Effects of Balloon Blowing Therapy With Percussion on Pulmonary Functions in Patients With Pneumonia
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Pneumonia is an infection of the lungs that is caused by bacteria, viruses, fungi, or parasites. It is characterized primarily by inflammation of the alveoli in the lungs or by alveoli that are filled with fluid (alveoli are microscopic sacs in the lungs that absorb oxygen). The symptoms of pneumonia can develop suddenly (over 24-48 hours) or may show more slowly, over several days. Common symptoms of pneumonia are likely to have a cough which can be dry, or may produce phlegm (thick mucus) that is yellow, green, brownish or bloodstained and breathing difficulty, wheezing and chest tightness where the rate will be high and the rhythm will be rapid and shallow. This activity encourages deep breathing, allowing a patient body to relax. Explain the patient that this exercise will help him or he can feel more relaxed. Make the patient to imagine that he/she is blowing up a balloon. Ask him/her to take in a deep breath; steadily and slowly blow up the huge balloon. See the balloon getting bigger, and bigger. Now ask the patient to close the eyes and imagine the balloon floating into the air. Let the patient continue blowing of balloons until he or she gets relaxed and calm. Percussion is a technique involving rhythmic tapping or clapping on the chest or back, serves as a means to move and loosen retained secretions within the airways. This mechanical intervention helps in removing mucus from the bronchial walls, and facilitates its expectoration and clearance.
This research methodology is likely to employ a randomized clinical trial design, dividing participants into two groups: group A will be receiving the combined therapy (Balloon blowing, percussion) for 7 days, while the Group B will be given intervention as Buteyko breathing techniques (ACBT, Percussion and deep breathing) for 3 weeks. Parameters such as breath auscultation by stethoscope, CASA Q questionnaire, Pulmonary function test will likely be utilized to gauge the efficacy of the combined intervention versus standard treatments. Anticipated outcomes encompass improvements in lung function metrics, clearer breath sounds denoting improved airway clearance, and potentially quicker recovery or shortened illness duration as compared to conventional treatments. If successful, this study could signify a more comprehensive and effective approach to manage pneumonia by combining specific therapies to enhance pulmonary functions and help in patients' recovery. Ultimately, these findings could contribute significantly to use respiratory therapy for individuals suffering from pneumonia
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Imran Amjad, PhD
- Phone Number: 03324390125
- Email: Imran.amjad@riphah.edu.pk
Study Contact Backup
- Name: Tasneem Shahzadi, Mphil
- Phone Number: 03104108327
- Email: Tasneem.shehzadi@ripha.edu.pk
Study Locations
-
-
Punjab
-
Lahore, Punjab, Pakistan, 54000
- Recruiting
- University of Lahore Teaching Hospital
-
Contact:
- Samia Sarmad, PHD
- Phone Number: 03004813195
- Email: info@hospital.uol.edu.pk
-
Contact:
- Jawad, MS-NMPT
- Phone Number: 03124047465
- Email: info@hospital.uol.edu.pk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
• Diagnosed pneumonia patients
Exclusion Criteria:
- Other respiratory complications
- Patients with surgeries
- Patients with neurological disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Balloon Blowing, Percussion
intervention will be given as blowing 10-15 balloons per day for 6 days.
05.minutes active cycle of breathing technique as baseline 10 minute to blowing 15 balloons 10 minutes percussion 25 minutes session
|
Ask the patient to take in a deep breath; steadily and slowly blow up the huge balloon.
See the balloon getting bigger, and bigger.
Now ask the patient to close the eyes and imagine the balloon floating into the air.
Let the patient continue blowing of balloons until he or she gets relaxed and calm.
Percussion is a technique involving rhythmic tapping or clapping on the chest or back, serves as a means to move and loosen retained secretions within the airways.
This mechanical intervention helps in removing mucus from the bronchial walls, and facilitates its expectoration and clearance
|
|
Active Comparator: Perccussion
intervention Will be given as Buteyko breathing techniques for 3 weeks.
15 Minutes ACBT with rest interval 10 minutes percussion 25 minutes session
|
Percussion is a technique involving rhythmic tapping or clapping on the chest or back, serves as a means to move and loosen retained secretions within the airways.
This mechanical intervention helps in removing mucus from the bronchial walls, and facilitates its expectoration and clearance
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
FEV1(Forced Expiratory Volume per second)
Time Frame: Pre and post after 1 week
|
Pulmonary Function Test using Digital Spirometer
|
Pre and post after 1 week
|
|
FVC (Forced Vital Capacity)
Time Frame: Pre and Post after 1 week
|
Pulmonary Function Test using Digital Spirometer
|
Pre and Post after 1 week
|
|
FEV1/FVC
Time Frame: Pre and Post after 1 week
|
Pulmonary Function Test using Digital Spirometer
|
Pre and Post after 1 week
|
|
CASA-Q (Cough and Sputum Assessment Questionnaire)
Time Frame: Pre and post after 1 week
|
To assess the Level of Cough and Sputum
|
Pre and post after 1 week
|
|
Auscultatory Breath Sound
Time Frame: pre and Post after 1 week
|
To assess the breath sound
|
pre and Post after 1 week
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Tasneem Shehzadi, Mphil, Riphah International University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REC/RCR & AHS/23/0371
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumonia
-
King Edward Memorial HospitalCompletedNosocomial Pneumonia | Healthcare-Associated Pneumonia | Aspiration Pneumonia | Ventilator-Associated PneumoniaIndia
-
Melinta Therapeutics, Inc.WithdrawnHospital-Acquired Bacterial Pneumonia | Ventilator-Associated Bacterial Pneumonia | Hospital-Acquired Pneumonia | Ventilator-Associated Pneumonia
-
Venatorx Pharmaceuticals, Inc.Biomedical Advanced Research and Development AuthorityWithdrawnHospital-acquired Pneumonia | Ventilator-associated Pneumonia
-
Universidad de la SabanaClínica Universidad de La Sabana; Universidad de La Sabana, ColombiaCompletedPneumococcal Pneumonia | Community Acquired Pneumonia (CAP)Colombia
-
University Medical Centre LjubljanaUniversity of Ljubljana, Faculty of MedicineUnknownCommunity Acquired Pneumonia | Ventilator Associated Pneumonia | Hospital Acquired PneumoniaSlovenia
-
Hannover Medical SchoolCharite University, Berlin, Germany; University of LeipzigUnknownCOVID-19 | Bacterial Pneumonia | Viral Pneumonia | Pneumonia Due to Streptococcus Pneumoniae | Pneumonia Due to H. Influenzae | Pneumonia, Organism Unspecified | Pneumonia in Diseases Classified Elsewhere | Pneumonia Due to Other Specified Infectious OrganismsGermany
-
Nantes University HospitalSociété Française d'Anesthésie et de RéanimationCompletedPneumonia | Sepsis | Ventilator-Associated Pneumonia | Hospital Acquired PneumoniaFrance
-
PfizerCompletedVentilator-associated Pneumonia (VAP) | Nosocomial Pneumonia (NP)Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, United Kingdom, Vietnam, Philippines, China, Ukraine, Argentina, Brazil, Hungary, Romania, India, Japan, Taiwan, Latvia, Czechia, Slov... and more
-
Arpida AGTerminatedHospital-Acquired Pneumonia | Ventilator-Associated Pneumonia | Health-Care-Associated Pneumonia
-
Hu YinanEnrolling by invitationSialic Acid | Superoxide Dismutase | Lipid PneumoniaChina
Clinical Trials on Balloon blowing
-
Riphah International UniversityRecruitingObesity, ChildhoodPakistan
-
Chulalongkorn UniversityCompleted
-
Escola Superior de Tecnologia da Saúde do PortoCompleted
-
Riphah International UniversityRecruitingPneumonia in ChildrenPakistan
-
Foundation University IslamabadRecruiting
-
Foundation University IslamabadRecruiting
-
Çankırı Karatekin UniversityCompleted
-
Chulalongkorn UniversityCompleted
-
Firat UniversityCompletedPain | Child Development | Nursing CareTurkey
-
Uşak UniversityCompletedOtitis Media With Effusion in Children | Otitis Media With Effusion (OME) | Breathing ExerciseTurkey (Türkiye)